The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
Open accessAbstract
Lipids and lipid nanoparticles are extensively employed as oral-delivery systems for drugs and other active ingredients. These have been exploited for many features in the field of pharmaceutical technology. Lipids usually enhance drug absorption in the gastrointestinal tract (GIT), and when formulated as nanoparticles, these molecules improve mucosal adhesion due to small particle size and increasing their GIT residence time. In addition, lipid nanoparticles may also protect the loaded drugs from chemical and enzymatic degradation and gradually release drug molecules from the lipid matrix into blood, resulting in improved therapeutic profiles compared to free drug. Therefore, due to their physiological and biodegradable properties, lipid molecules may decrease adverse side effects and chronic toxicity of the drug-delivery systems when compared to other of polymeric nature. This paper highlights the importance of lipid nanoparticles to modify the release profile and the pharmacokinetic parameters of drugs when administrated through oral route.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Drug Development and Industrial Pharmacy
Rhodes, C. T. (1995) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049509070870 · Cited by 1,263
Solid lipid nanoparticles: A modern formulation approach in drug delivery system
Mukherjee, S., Ray, S., & Thakur, R. (2009) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.57282 · Cited by 1,000
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Hauss, D. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.006 · Cited by 595
Jenning, V., Thünemann, A. F., & Gohla, S. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00378-1 · Cited by 593
In vitro assessments of nanomaterial toxicity
Jones, C. F., & Grainger, D. W. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.005 · Cited by 554
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Bioadhesive microspheres as a controlled drug delivery system
Vasir, J. K., Tambwekar, K., & Garg, S. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00087-5 · Cited by 524
Müller, R. H., Mehnert, W., Lucks, J. S., Schwarz, C., Mühlen, A. Z., Meyhers, H., de Freitas, C. F., & Rühl, D. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 455
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications
Meunier, V., Bourri�, M., Berger, Y., & Fabre, G. (1995) · Cell Biology and Toxicology · doi:10.1007/bf00756522 · Cited by 434
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability
Luo, Y., Chen, D., Ren, L., Zhao, X., & Qin, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.010 · Cited by 395
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Oral insulin delivery by means of solid lipid nanoparticles.
Sarmento, B. F. C. C., Martins, S., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 363
Self-citationExploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin
Kakkar, V., Singh, S., Singla, D., & Kaur, I. P. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000310 · Cited by 348
Solid lipid nanoparticles as drug delivery systems
Manjunath, K., Reddy, J. S., & Venkateswarlu, V. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.2.876286 · Cited by 306
Sek, L., Porter, C. J. H., Kaukonen, A. M., & Charman, W. N. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021771896 · Cited by 304
Silva, A. C., González-Mira, E., García, M. L., Egea, M. A., Fonseca, J., Silva, R., Santos, D., Souto, E. B., & Ferreira, D. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.03.035 · Cited by 300
Self-citationGöppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Schubert, M. A., & Müller-Goymann, C. C. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.03.006 · Cited by 297
Kheradmandnia, S., Vasheghani-Farahani, E., Nosrati, M., & Atyabi, F. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.06.003 · Cited by 278
Das, S., Ng, W. K., Kanaujia, P., Kim, S., & Tan, R. B. H. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.07.036 · Cited by 274
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
Aji Alex, M. R., Chacko, A. J., Jose, S., & Souto, E. B. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.10.002 · Cited by 258
Self-citationSolid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
Abdelbary, G., & Fahmy, R. H. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9197-2 · Cited by 246
Müller, R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04539-5 · Cited by 242
The comet assay in nanotoxicology research
Karlsson, H. L. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3977-0 · Cited by 235
Vivek, K., Reddy, H., & Murthy, R. S. R. (2007) · AAPS PharmSciTech · doi:10.1208/pt0804083 · Cited by 234
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Yuan, H., Wang, L.-L., Du, Y.-Z., You, J., Hu, F.-Q., & Zeng, S. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.06.011 · Cited by 215
Lipid Nanoparticles: Effect on Bioavailability and Pharmacokinetic Changes
Souto, E. B., & Müller, R. H. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_4 · Cited by 210
Self-citationLipid nanoparticles for the delivery of poorly water-soluble drugs
Bunjes, H. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01024.x · Cited by 207
Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery
Lv, Q., Yu, A., Xi, Y., Li, H., Song, Z., Cui, J., Cao, F., & Zhai, G. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.014 · Cited by 205
HUANG, Z.-R., HUA, S.-C., YANG, Y.-L., & FANG, J.-Y. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00829.x · Cited by 200
MULLER, R. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199
Influence of emulsifiers on the crystallization of solid lipid nanoparticles
Bunjes, H., Koch, M. H. J., & Westesen, K. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10413 · Cited by 197
Non-destructive methods of characterization of risperidone solid lipid nanoparticles
Rahman, Z., Zidan, A. S., & Khan, M. A. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.05.003 · Cited by 197
Influence of hydrophilic surfactants on the properties of multiple W/O/W emulsions
Schmidts, T., Dobler, D., Nissing, C., & Runkel, F. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.06.033 · Cited by 194
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
Yassin, A. E. B., Anwer, M. K., Mowafy, H. A., El-Bagory, I. M., Bayomi, M. A., & Alsarra, I. A. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.398 · Cited by 188
Studies on oral absorption of stearic acid SLN by a novel fluorometric method
Yuan, H., Chen, J., Du, Y.-Z., Hu, F.-Q., Zeng, S., & Zhao, H.-L. (2007) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2007.03.002 · Cited by 176
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C., & Mumper, R. J. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1021 · Cited by 174
Nassimi, M., Schleh, C., Lauenstein, H. D., Hussein, R., Hoymann, H. G., Koch, W., Pohlmann, G., Krug, N., Sewald, K., Rittinghausen, S., et al. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.014 · Cited by 173
Preparation and characterization of solid lipid nanoparticles containing peptide
Hu, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.016 · Cited by 168
Eldem, T., Speiser, P., & Hincal, A. (1991) · Pharmaceutical Research · doi:10.1023/a:1015874121860 · Cited by 165
Luo, C.-F., Yuan, M., Chen, M.-S., Liu, S.-M., Zhu, L., Huang, B.-Y., Liu, X.-W., & Xiong, W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.064 · Cited by 158
Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy
Kang, K. W., Chun, M., Kim, O., Subedi, R. K., Ahn, S., Yoon, J., & Choi, H. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.006 · Cited by 156
Xie, S., Zhu, L., Dong, Z., Wang, X., Wang, Y., Li, X., & Zhou, W. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.12.014 · Cited by 156
Formulation and Evaluation of Solid Lipid Nanoparticles of a Water Soluble Drug: Zidovudine
Singh, S. K., Dobhal, A. K., Jain, A., Pandit, J. K., & Chakraborty, S. (2010) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.58.650 · Cited by 155
Zimmermann, E., & Müller, R. H. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00167-9 · Cited by 151
Schöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Tsai, M.-J., Huang, Y.-B., Wu, P.-C., Fu, Y.-S., Kao, Y.-R., Fang, J.-Y., & Tsai, Y.-H. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22285 · Cited by 137
Physical Chemical Considerations of Lipid-Based Oral Drug Delivery-Solid Lipid Nanoparticles
Bummer, P. M. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i1.10 · Cited by 137
Development and characterization of lipid microparticles as a drug carrier for somatostatin
Reithmeier, H., Herrmann, J., & Göpferich, A. M. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00620-2 · Cited by 132
Cavalli, R. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00066-6 · Cited by 125
Rawat, M. K., Jain, A., & Singh, S. K. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22435 · Cited by 123
Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
Hu, L., Xing, Q., Meng, J., & Shang, C. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9410-3 · Cited by 116
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
Başaran, E., Demirel, M., Sırmagül, B., & Yazan, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652040902846883 · Cited by 114
Solid lipid nanoparticles produced through a coacervation method
Battaglia, L., Gallarate, M., Cavalli, R., & Trotta, M. (2010) · Journal of Microencapsulation · doi:10.3109/02652040903031279 · Cited by 113
Heiati, H., TAWASHI, R., & Phillips, N. C. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006847 · Cited by 113
Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles
Jensen, L. B., Magnussson, E., Gunnarsson, L., Vermehren, C., Nielsen, H. M., & Petersson, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.022 · Cited by 109
Varshosaz, J., Tabbakhian, M., & Mohammadi, M. Y. (2009) · Journal of Liposome Research · doi:10.3109/08982100903443065 · Cited by 106
Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel
Pandita, D., Ahuja, A., Lather, V., Benjamin, B., Dutta, T., Velpandian, T., & Khar, R. K. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9636-8 · Cited by 105
In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain
Montenegro, L., Campisi, A., Sarpietro, M., Carbone, C., Acquaviva, R., Raciti, G., & Puglisi, G. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.539231 · Cited by 92
Shukla, D., Chakraborty, S., Singh, S., & Mishra, B. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.547469 · Cited by 82
Yang, R., Gao, R., Li, F., He, H., & Tang, X. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.497151 · Cited by 78
del Pozo‐Rodríguez, A., Delgado, D., Solinís, M. Á., Pedraz, J. L., Echevarrı́a, E., Rodríguez, J. M., & Rodríguez‐Gascón, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.020 · Cited by 77
Percutaneous Permeation of Betamethasone 17-Valerate Incorporated in Lipid Nanoparticles
Zhang, J. C., & Smith, E. W. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22329 · Cited by 76
Zhang, X., Pan, W., Gan, L., Zhu, C., Gan, Y., & Nie, S. (2008) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.56.1645 · Cited by 75
Focus on Skin as a Possible Port of Entry for Solid Nanoparticles and the Toxicological Impact
Smijs, T. G. M., & Bouwstra, J. A. (2010) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2010.1146 · Cited by 75
Weyhers, H., Ehlers, S., Hahn, H. H., et al. (2006) · PubMed · Cited by 73
Xie, S., Pan, B., Wang, M., Zhu, L., Wang, F., Dong, Z., Wang, X., & Zhou, W. (2010) · Nanomedicine · doi:10.2217/nnm.10.42 · Cited by 72
Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles
Zhou, W., Xie, S., Zhu, L., Dong, Z., Wang, Y., & Wang, X. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17083 · Cited by 72
Pandita, D., Pandita, D., Ahuja, A., Velpandian, T., Lather, V., Dutta, T., & Khar, R. K. (2009) · Die Pharmazie · doi:10.31083/ph.2009.8338 · Cited by 64
Solid lipid nanoparticles for drug delivery
Harms, M., & Müller-Goymann, C. C. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50008-5 · Cited by 62
Kržič, M., Šentjurc, M., & Kristl, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00351-5 · Cited by 55
Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility
Potta, S. G., Minemi, S., Nukala, R. K., Peinado, C., Lamprou, D. A., Urquhart, A. J., & Douroumis, D. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.529948 · Cited by 52
Li, R., Eun, J. S., & Lee, M.-K. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0220-2 · Cited by 51
Souto, E. B., Doktorovová, S., & Boonme, P. (2011) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(11)50005-x · Cited by 49
Self-citationSolid lipid nanoparticles in cancer therapy.
Mathur, V., Satrawala, Y., Rajput, M. S., Kumar, P., Shrivastava, P., & Vishvkarma, A. (2010) · International Journal of Drug Delivery · doi:10.5138/ijdd.2010.0975.0215.02029 · Cited by 48
Olbrich, C., Schöler, N., Tabatt, K., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023754 · Cited by 44
Wang, T., Wang, N., Zhang, Y., Shen, W., Gao, X., & Li, T. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.04.005 · Cited by 42
Montisci, M., Dembri, A., Giovannuci, G., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011044730790 · Cited by 40
Chakraborty, S., Shukla, D., Vuddanda, P. R., Mishra, B., & Singh, S. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.07.058 · Cited by 39
Priano, L., Zara, G. P., Assawy, N. E., Cattaldo, S., Muntoni, E., Milano, E., Serpe, L., Musicanti, C., Pérot, C., Gasco, M. R., et al. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.009 · Cited by 39
Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR
Kristl, J., Volk, B., Ahlin, P., et al. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00070-x · Cited by 38
Severino, P. B., Pinho, S. C., Souto, E. B., & Santana, M. H. A. (2011) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-011-1613-7 · Cited by 37
Self-citationWei, W., Shi, S., Liu, J., Sun, X., Ren, K., Zhao, D. M., Zhang, X., Zhang, Z., & Gong, T. (2010) · Journal of drug targeting · doi:10.3109/10611861003599461 · Cited by 37
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for Dermal Delivery
R. H. Mu¨ller, W. M. (2005) · CRC Press eBooks · doi:10.1201/9780849359033-56 · Cited by 33
Xu, X., Wang, Y., Chen, R.-Y., Feng, C., Yao, F., Tong, S., Wang, L., Yamashita, F., & Yu, J. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.260 · Cited by 27
da Silva, C. F., Severino, P. B., Martins, F., Chaud, M. V., & Santana, M. H. A. (2009) · Journal of Microencapsulation · doi:10.1080/02652040802466691 · Cited by 23
Self-citationEffect of PEG2000 on drug delivery characterization from solid lipid nanoparticles.
Hong, Y., Hu, F., & Yuan, H. (2006) · PubMed · Cited by 20
Trotta, M., Carlotti, M. E., Gallarate, M., Zara, G. P., Muntoni, E., & Battaglia, L. (2011) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2010.488497 · Cited by 19
In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery
Liu, C., Liu, D., Bai, F., Zhang, J., & Zhang, N. (2010) · Drug Delivery · doi:10.3109/10717541003762839 · Cited by 17
M Cells Prefer Archaeosomes: An In Vitro/In Vivo Snapshot Upon Oral Gavage in Rats
Morilla, M. J., Gómez, D. L. M., Cabral, P., Cabrera, M., Balter, H. S., Tesoriero, M. V. D., Higa, L. H., Roncaglia, D. I., & Romero, E. L. (2011) · Current Drug Delivery · doi:10.2174/156720111795256138 · Cited by 14
Cited by
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Humic acids: Structural properties and multiple functionalities for novel technological developments
de Melo, B. A. G., Motta, F. L., & Santana, M. H. A. (2016) · Materials Science and Engineering: C · doi:10.1016/j.msec.2015.12.001 · Cited by 780
Self-citationSkin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Edis, Z., Wang, J., Waqas, M. K., Ijaz, M., & Ijaz, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s289443 · Cited by 390
Metadata
- Authors
- Severino, P., Andreani, T., Macedo, A. S., Fangueiro, J. F., Santana, M. H. A., Silva, A. M., & Souto, E. B.
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2012-11-24
- Volume
- 2012
- Pages
- 1-10
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- OpenAlex
- W2012179823
- Cited by
- 276
- References
- 101
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.